von Willwbrands Disease - Most Important Points
Most common congenital bleeding disorder, affecting 1-2 percent of the population.
vWF - is synthesized by the vascular endothelium, and a cofactor for platelet adhesion and a co factor for factor VIII
Forms the clot for the vascular injury site - and attaches
3 types- I,II,III
vWF - is synthesized by the vascular endothelium, and a cofactor for platelet adhesion and a co factor for factor VIII
Forms the clot for the vascular injury site - and attaches
3 types- I,II,III
- mild quantitative, 90 % present - most common - less serious
- quantitative defect - less vWF - more serious
- Absent - vWF is almost absent - most serious
Clinical features: Bleeding particularly in children
- Mild -
- asymptomatic
- Mucosal or cutaneoous bleeding - easy bruising, gingival bleeding, epistaxis, menorrhagia
- Moderate to severe
- Soft-tissue hematomas, petechiae (rare), GI Bleed and hemarthroses
Investigations:
- Coagulation profile - increased bleeding time and PTT
- low factor VIII (5 to 50%) (PT and factor VIII is normal - also blood group O has 30% less vWF)
- platelet count normal
- reduced ristocetin cofactor activity (normally causes vWF to bind platelets tightly)
- analysis of vWF multimeres
Treatment
- Avoid Asprin and Heparin
- Desmopressin (DDAVP) for type I vWD
- causes the release of vWF and factor VIII from endothelial cells
- (after 4 doses patients develop tachyphylaxis)
- Highly purified factor VIII concentrate containing vWF (HEMATE) in selected cases and Type II
- conjugated estrogens (increase vWF - oral contraceptives)
- Platelet transfusions cyroprecipitates
- Control the bleeding - epistaxis - surgical strips
Prognosis
- fluctuates and improves during pregnancy and with age
Comments
Post a Comment